Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Cephalon CEO Sees FTC Suit as Business-As-Usual
Link ID 3291
Title Cephalon CEO Sees FTC Suit as Business-As-Usual
Url http://www.medscape.com/viewarticle/570271?src=rss
Description Frank Baldino, the chief executive of Cephalon Inc , says he is not concerned about a suit filed against the company by the U.S. Federal Trade Commission. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date Feb 16, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Why Should I Report an Adverse Drug Event?
  Individual clinicians can play a vital role in detecting potentially serious adverse drug events -- and the safety of our drug supply depends on them.
Medscape Pharmacists
Category:   Articles > Business of Medicine


2. Gardasil Approval Expanded to Prevention of HPV-Related Vulvar, Vaginal Cancer
  The FDA has approved the vaccine Gardasil for the prevention of vaginal and vulvar cancer caused by human papillomavirus (HPV) types 16 and 18 in girls and women aged 9 to 26 years. Medscape Medical News
Category:   Articles > Business of Medicine


3. Emergency Waits Get Dangerously Long in U.S.: Study
  Patients seeking urgent care in U.S. emergency rooms are waiting longer than in the 1990s, U.S. researchers reported on Tuesday. Reuters Health Information
Category:   Articles > Business of Medicine


4. Aetna Sets External Review of Rescinded Policies
  Health insurer Aetna Inc. said on Monday it had appointed an independent panel of doctors to decide on rescinding policies that were obtained by false or incomplete information, effective immediately. Reuters Health Information
Category:   Articles > Business of Medicine


5. FDA Device Clearances: Genetic Test for Breast Cancer, Cervical Disc Replacement Device, Digital Cys
  The FDA has approved a Premarket Application for a genetic test for breast cancer (TOP2A FISH pharmDx assay) and granted 510(k) clearance for a cervical disc replacement device (ProDisc-C) and a digital cystoscope (CST-5000 flexible video cystoscope). Medscape Medical News
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS